Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-21-141628
Date:2021-11-17
Issuer: INHIBIKASE THERAPEUTICS, INC. (IKT)
Original Submission Date:

Reporting Person:

WERNER MILTON H.
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA, GA 30339

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-11-17 P 17,569 a $1.98 23,589 indirect
COMMON STOCK 2021-11-17 P 1,100 a $1.97 23,589 indirect
COMMON STOCK 2021-11-17 P 3,186 a $1.96 23,589 indirect
COMMON STOCK 2021-11-17 P 1,334 a $1.94 23,589 indirect
COMMON STOCK 2021-11-17 P 400 a $1.93 23,589 indirect
COMMON STOCK 2021-11-17 0 $0.00 5,293,580 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of section 16 or for any other purpose.
WhaleWisdom Logo

Elevate your investments